MetLife Investment Management’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.6M | Buy |
7,568
+493
| +7% | +$90.5K | 0.01% | 1283 |
|
|
2026
Q1 | $1.13M | Sell |
7,075
-67
| -0.9% | -$10.3K | 0.01% | 1339 |
|
|
2025
Q4 | $979K | Sell |
7,142
-359
| -5% | -$46.4K | ﹤0.01% | 1441 |
|
|
2025
Q3 | $911K | Hold |
7,501
| – | – | ﹤0.01% | 1499 |
|
|
2025
Q2 | $803K | Hold |
7,501
| – | – | ﹤0.01% | 1428 |
|
|
2025
Q1 | $696K | Sell |
7,501
-97
| -1% | -$9.4K | ﹤0.01% | 1540 |
|
|
2024
Q4 | $817K | Buy |
7,598
+436
| +6% | +$53K | ﹤0.01% | 1522 |
|
|
2024
Q3 | $901K | Hold |
7,162
| – | – | 0.01% | 1452 |
|
|
2024
Q2 | $776K | Buy |
7,162
+543
| +8% | +$52.9K | ﹤0.01% | 1490 |
|
|
2024
Q1 | $626K | Hold |
6,619
| – | – | ﹤0.01% | 1558 |
|
|
2023
Q4 | $612K | Hold |
6,619
| – | – | ﹤0.01% | 1572 |
|
|
2023
Q3 | $423K | Hold |
6,619
| – | – | ﹤0.01% | 1728 |
|
|
2023
Q2 | $409K | Hold |
6,619
| – | – | ﹤0.01% | 1835 |
|
|
2023
Q1 | $384K | Hold |
6,619
| – | – | ﹤0.01% | 1807 |
|
|
2022
Q4 | $394K | Hold |
6,619
| – | – | ﹤0.01% | 1797 |
|
|
2022
Q3 | $419K | Hold |
6,619
| – | – | ﹤0.01% | 1759 |
|
|
2022
Q2 | $463K | Hold |
6,619
| – | – | ﹤0.01% | 1719 |
|
|
2022
Q1 | $465K | Buy |
6,619
+1,373
| +26% | +$92.3K | ﹤0.01% | 1813 |
|
|
2021
Q4 | $356K | Hold |
5,246
| – | – | ﹤0.01% | 1695 |
|
|
2021
Q3 | $367K | Hold |
5,246
| – | – | ﹤0.01% | 1711 |
|
|
2021
Q2 | $367K | Hold |
5,246
| – | – | ﹤0.01% | 1758 |
|
|
2021
Q1 | $409K | Hold |
5,246
| – | – | ﹤0.01% | 1645 |
|
|
2020
Q4 | $348K | Hold |
5,246
| – | – | ﹤0.01% | 1676 |
|
|
2020
Q3 | $327K | Hold |
5,246
| – | – | ﹤0.01% | 1585 |
|
|
2020
Q2 | $333K | Hold |
5,246
| – | – | ﹤0.01% | 1604 |
|
|
2020
Q1 | $376K | Hold |
5,246
| – | – | 0.01% | 1364 |
|
|
2019
Q4 | $453K | Hold |
5,246
| – | – | ﹤0.01% | 1517 |
|
|
2019
Q3 | $429K | Hold |
5,246
| – | – | ﹤0.01% | 1503 |
|
|
2019
Q2 | $426K | Sell |
5,246
-10,492
| -67% | -$810K | ﹤0.01% | 1580 |
|
|
2019
Q1 | $1.19M | Buy |
15,738
+10,492
| +200% | +$832K | ﹤0.01% | 1557 |
|
|
2018
Q4 | $412K | Hold |
5,246
| – | – | 0.01% | 1486 |
|
|
2018
Q3 | $395K | Hold |
5,246
| – | – | ﹤0.01% | 1681 |
|
|
2018
Q2 | $369K | Hold |
5,246
| – | – | ﹤0.01% | 1599 |
|
|
2018
Q1 | $313K | Hold |
5,246
| – | – | ﹤0.01% | 1654 |
|
|
2017
Q4 | $320K | Buy |
+5,246
| New | +$335K | ﹤0.01% | 1672 |
|
Other funds holding NHC
MSIIA
MetLife Investment Management's NHC Position: Q2 2026 in Review
MetLife Investment Management increased its National Healthcare (NHC) stake by 7% in Q2 2026, buying an estimated $90.5K and bringing the position to 7,568 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #1283.
MetLife Investment Management first reported a position in NHC in Q4 2017 and has held it in 35 quarters since. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.
- MetLife Investment Management held 7,568 shares of National Healthcare worth $1.6M as of Q2 2026.
- MetLife Investment Management bought 493 National Healthcare shares in Q2 2026, an estimated $90.5K.
- National Healthcare made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1283 holding.
- MetLife Investment Management first reported a position in National Healthcare in Q4 2017 and has held it in 35 quarters since.
- 249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.